![]() |
| Dr Monique Kilkenny |
Featured post
SCS research and awards news
For all our research and awards news, please visit our news page.
Showing posts with label monique kilkenny. Show all posts
Showing posts with label monique kilkenny. Show all posts
Wednesday, 27 May 2020
Dr Monique Kilkenny's paper recognised as one of the most read in Medical Journal of Australia
Wednesday, 26 February 2020
SCS researchers’ part of a team awarded $5 million to stop stroke in its tracks
| Professor Amanda Thrift |
Thursday, 7 November 2019
Professor Cadilhac and Professor Kilkenny forge new international collaboration
| Professor Cadilhac and Professor Wang |
Wednesday, 16 October 2019
One-third of stroke patients ditch meds within a year
A study led by Dr Monique Kilkenny from the Stroke and Ageing Research Group has been published in Australian Doctor.
Wednesday, 21 August 2019
SCS staff receive Dean's Awards for Excellence
The School of Clinical Sciences is celebrating the outstanding achievements of Dr Monique Kilkenny of the Department of Medicine and the Monash Nutrition Indigenous Curriculum Working Group for their recognition in the 2019 Dean’s Awards for Excellence held earlier this month.
Wednesday, 13 February 2019
Maximising data value and avoiding data waste: a validation study in stroke research
![]() |
| Dr Monique Kilkenny |
Recent advances in digital infrastructure has allowed linkage of administrative and clinical datasets. Dr Monique Kilkenny recently led the linkage of the Australian Stroke Clinical Registry with hospital administrative datasets. Stroke is a leading cause of death and disability in Australia and with this linked dataset, researchers will be able to reliably investigate the characteristics of patients who are rehospitalised and if these hospitalisations are potentially preventable.
Monday, 10 September 2018
Publications week ending 7 September 2018
Elective replacement of intravenous cannula in neonates-a randomised trial. Atul Malhotra et al. published in the European Journal of Pediatrics.
Planned private homebirth in Victoria 2000–2015: a retrospective cohort study of Victorian perinatal data. Miranda Davies-Tuck et al. published in BMC Pregnancy and Childbirth.
The NACSTOP trial: A multi‐center, cluster‐controlled trial of early cessation of acetylcysteine in acetaminophen overdose. Anselm Wong et al. published in Hepatology.
Planned private homebirth in Victoria 2000–2015: a retrospective cohort study of Victorian perinatal data. Miranda Davies-Tuck et al. published in BMC Pregnancy and Childbirth.
The NACSTOP trial: A multi‐center, cluster‐controlled trial of early cessation of acetylcysteine in acetaminophen overdose. Anselm Wong et al. published in Hepatology.
Monday, 14 May 2018
Data quality: "Garbage in - garbage out"
Monique Kilkenny et al. published in the Health Information Management Journal.
Monday, 26 February 2018
Monday, 19 February 2018
Monday, 12 February 2018
Monday, 5 February 2018
Monash researchers making their mark in stroke
![]() |
| Professor Dominique Cadilhac |
$100,000 in Stroke Foundation seed grants.
Dr Monique Kilkenny and Professor Dominique Cadilhac, from the Stroke and Ageing group within the School of Clinical Sciences at Monash Health, will benefit from the 2018 grants round as they strive to improve diagnosis, treatment and long-term prevention care for survivors of stroke.
Dr Kilkenny’s research will look at the long term use of medications prescribed to stroke survivors to reduce their chance of subsequent stroke.
![]() |
| Dr Monique Kilkenny |
“During the first 10 years after a stroke there is a 43 percent risk of a person experiencing another stroke, and generally these are more severe. Several types of medications have been shown to
prevent strokes within this high risk population,” Dr Kilkenny said.
“It is essential these medications are taken as prescribed on an ongoing basis. This grant will allow us to understand whether patients continue to take prescribed medications, such as those for
lowering blood pressure and cholesterol, after they leave hospital and in the long-term and what impact these actions have on health.”
While Professor Cadilhac’s project will look at how our ambulances and hospitals respond to suspected stroke events and how diagnosis and access to time-critical treatment can be improved. The
research will utilise data that will for the first time be linked from the Australian Stroke Clinical
Registry and Ambulance Victoria.
“Diagnosis of acute stroke is complex” Professor Cadilhac said.
“In Australia, not all patients with stroke are admitted to hospitals within the required time frames
for time-critical treatments.”
“Through this work we will learn more about the pre-hospital factors which influence the
identification of a stroke and the impact of this on the patient’s timely arrival at hospital. The
outcome may have important implications for practice or policy,” she said.
Stroke Foundation Chief Executive Officer Sharon McGowan said these projects had the potential
to make a real difference for patients with stroke, from detection to long term care.
“Tragically, it’s estimated there will be more than 56,000 strokes across the country in 2018 – that’s
one every nine minutes,” Ms McGowan said.
“Too many Australians are dying or being left with an ongoing disability as a result of stroke, but it
does not need to be this way.
“High quality evidence-based research like this is so important in our mission to prevent, treat and
beat this terrible disease and reduce the spiraling costs to the community and health system
associated with stroke.
Researchers like Dr Monique Kilkenny and Professor Dominique Cadilhac give us hope for the
future,” she said.
Monday, 27 November 2017
Monday, 13 November 2017
The Quality of Discharge Care Planning in Acute Stroke Care: Influencing Factors and Association with Postdischarge Outcomes
Nadine Andrew et al. published in the Journal of Stroke and Cerebrovascular Diseases.Read article here.
Monday, 25 September 2017
Monday, 8 May 2017
Monday, 1 May 2017
Monday, 10 April 2017
Improving care for patients with stroke impacts health outcomes and the economy
![]() |
| Associate Professor Cadilhac |
Monash University researchers from Stroke and Ageing
Research, School of Clinical Sciences at Monash Health, have shown that if
acute stroke care was improved to that of Australian benchmarks, more than 9300
disability-adjusted life years could be avoided every year, at minimal cost to
the health system.
Stroke is a leading cause of death and disability in Australia,
and the associated economic burden is significant.
“The average lifetime
costs of first-ever stroke in Australia is approximately $100,000, comprising
health costs and loss of productivity,” said senior researcher Associate
Professor Dominique Cadilhac.
“While acute stroke treatment guidelines include stroke unit
care, intravenous thrombolysis for patients with ischemic stroke and medication
for secondary prevention, evidence suggests that eligible patients may not
always receive these therapies—even in well-resourced settings.”
The research team estimated the health and economic benefits
from improving standards of care, and converted their results to
disability-adjusted life years (DALYs) avoided.
A DALY is a year of life lost due to illness, disability, or early
death.
“Using 2013 patient data, we estimated that if hospitals had
achieved the benchmark acute stroke care standards, 285 recurrent strokes and
977 deaths or disabilities would have been prevented,” said Dr Joosup Kim who
did the modelling analysis.
“This translates to 9329 DALYs avoided; and these health
benefits could be delivered at an additional cost of $30.8 million or
approximately $3304 per DALY avoided.”
Dr Kim explained that considerable gains in health may be
achieved at relatively low costs by improving the average standard of acute
stroke care in Australia to the standard of top performing hospitals.
“The estimate of $3304 per DALY avoided is considered to be
highly cost effective since the willingness to pay for an additional year of
healthy life is generally accepted as less than the national annual gross
domestic project per capita (approximately $50,000 in Australia).”
The evidence-based therapies included in the research team’s
analysis are already recommended in guidelines, further emphasising the
potential benefits of implementing current knowledge.
“These are benefits that could be achieved with investment
in clinician behaviour change, health service redesign, and support structures
within the clinical setting to attain achievable benchmarks,” said Associate
Professor Cadilhac.
Monday, 27 March 2017
Subscribe to:
Posts (Atom)














